Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Classical hematology 2Plasma cell 1Myeloid 1

Conditions

Myelodysplastic Syndromes 40Leukemia 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 31Lymphoma 29Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma, Mantle-Cell 25Lymphoma, Follicular 25Lymphoma, Non-Hodgkin 24Leukemia, Myeloid, Chronic-Phase 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myeloid, Accelerated Phase 22Lymphoma, Large B-Cell, Diffuse 21Hodgkin Disease 21Burkitt Lymphoma 21Anemia, Refractory, with Excess of Blasts 21Multiple Myeloma 20Myeloproliferative Disorders 17Lymphoma, Large-Cell, Immunoblastic 17Congenital Abnormalities 17Blast Crisis 17Dendritic Cell Sarcoma, Interdigitating 16Anemia, Refractory 15Recurrence 14Neoplasms, Plasma Cell 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Primary Myelofibrosis 12Leukemia, Biphenotypic, Acute 12Myelodysplastic-Myeloproliferative Diseases 11

Interventions

Cyclophosphamide 21fludarabine phosphate 18Whole-Body Irradiation 17Melphalan 15fludarabine 14Tacrolimus 14Busulfan 12Mycophenolic Acid 11Peripheral Blood Stem Cell Transplantation 10Alemtuzumab 8Methotrexate 5Cyclosporine 5Antilymphocyte Serum 5thymoglobulin 3Thiotepa 3Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3sargramostim 2Transplantation 2Sirolimus 2Rituximab 2Methylprednisolone 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2Etoposide 2Cord Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Anemia, Aplastic × Cord Blood Stem Cell Transplantation × Clear all
NCT00053989 2020-02-10

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Roswell Park Cancer Institute

Phase 2 Completed
41 enrolled 13 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Fanconi Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00212407 2018-11-02

New York Blood Center National Cord Blood Program

New York Blood Center

Phase EARLY_PHASE1 Terminated
4,476 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡